Frances Anastassacos, Co-Founder and President of Nabla Bio
- Harvard Grid
- Apr 10
- 1 min read
Nabla Bio is expanding the universe of druggable targets with AI-powered protein design.
Lab-to-Launch Lounge
Thursday, March 27, 2025
Frances Anastassacos, PhD, is President and Co-Founder of Nabla Bio, Inc., a Series A stage biotech start-up focused on using AI and multiplex biology to enhance biologics design. She completed her PhD at Harvard in 2019 and has prior experience in venture capital at Flagship Pioneering, as well as roles in pharma and consulting. Frances holds a master’s degree in Chemistry from the University of St. Andrews. At Nabla, Frances' responsibilities span technical, business, and legal areas to drive the company’s mission.
One piece of advice to Venturing@Harvard
West coast investors take a founder-first approach while east coast investors are more focused on product market fit
